{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Melioidosis: Emerging Beyond Endemic Areas

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain the epidemiology of melioidosis.
  2. Select the typical clinical presentation of patients with melioidosis.
  3. Identify the proper labeling of lab specimens when evaluating a patient for melioidosis.
  4. Select antimicrobials to treat patients with melioidosis.
  5. Identify a strategy to prevent infection with B. pseudomallei.

Learning Outcomes

Participants will demonstrate competency in clinical reasoning regarding the management of patients with melioidosis by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $17.95


  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 2.0 CH
  • NM - BON 1.5 CH
  • SC - BON 1.5 CH
  • WV - BOERN 1.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Test Code: N1022B
Published: Oct 2022
Expires: 9/5/2025
Sources: Nursing2022
Required Passing Score: 8/10 (80%)
Authors: Dorothy Borton, BSN, RN, CIC, FAPIC
Categories: Infection , Medical-Surgical